iCAD, Inc. (ICAD)
NASDAQ: ICAD · Real-Time Price · USD
2.005
-0.055 (-2.67%)
Apr 1, 2025, 10:39 AM EDT - Market open
iCAD, Inc. Employees
As of December 31, 2023, iCAD, Inc. had 69 total employees, including 67 full-time and 2 part-time employees. The number of employees decreased by 40 or -36.70% compared to the previous year.
Employees
69
Change (1Y)
-40
Growth (1Y)
-36.70%
Revenue / Employee
$284,174
Profits / Employee
-$81,391
Market Cap
52.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ICAD News
- 12 days ago - iCAD, Inc. (ICAD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 12 days ago - iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024 - GlobeNewsWire
- 26 days ago - iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America - GlobeNewsWire
- 4 weeks ago - Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025 - GlobeNewsWire
- 5 weeks ago - iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025 - GlobeNewsWire
- 2 months ago - iCAD Pre-Announces Estimated Q4 2024 Revenue - GlobeNewsWire
- 2 months ago - Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions - Newsfile Corp
- 3 months ago - SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations - GlobeNewsWire